Literature DB >> 19478550

Contractility of diabetic human corpus cavernosum smooth muscle in response to serotonin mediated via Rho-kinase.

Nergis Murat1, Burak Cem Soner, Omer Demir, Adil Esen, Sedef Gidener.   

Abstract

BACKGROUND/AIMS: Serotonin (5-hydroxytryptamine, 5-HT)-induced contraction and the involvement of RhoA/Rho-kinase pathway in the 5-HT-induced contraction was investigated isometrically in vitro in both diabetic and nondiabetic human corpus cavernosum (HCC) tissues.
METHODS: HCC tissues were obtained from 12 patients. The response to 5-HT (10(-9) to 10(-5) mol/l) was studied in isolated HCC tissues in the absence and in the presence of a Rho-kinase inhibitor (Y-27632).
RESULTS: Preincubation with Y-27632 attenuated maximum contractions induced by 5-HT in tissues of both nondiabetics and diabetics. When diabetic and nondiabetic groups were compared, no significant difference was seen in 5-HT-induced contraction alone, but in the presence of Y-27632, 5-HT-induced contraction was significantly higher in the diabetic group.
CONCLUSION: These results suggest that the Rho-kinase-mediated pathway plays an important role for 5-HT-induced contraction in diabetic corpus cavernosum tissues.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19478550     DOI: 10.1159/000221380

Source DB:  PubMed          Journal:  Pharmacology        ISSN: 0031-7012            Impact factor:   2.547


  2 in total

1.  The selective Rho-kinase inhibitor azaindole-1 has long-lasting erectile activity in the rat.

Authors:  George F Lasker; Edward A Pankey; Alexander V Allain; Subramanyam N Murthy; Johannes-Peter Stasch; Philip J Kadowitz
Journal:  Urology       Date:  2013-02       Impact factor: 2.649

Review 2.  Basic Science Evidence for the Link Between Erectile Dysfunction and Cardiometabolic Dysfunction.

Authors:  Biljana Musicki; Anthony J Bella; Trinity J Bivalacqua; Kelvin P Davies; Michael E DiSanto; Nestor F Gonzalez-Cadavid; Johanna L Hannan; Noel N Kim; Carol A Podlasek; Christopher J Wingard; Arthur L Burnett
Journal:  J Sex Med       Date:  2015-12-08       Impact factor: 3.802

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.